Content on this site is intended for US RESIDENTS ONLY

Every Day Is Different. That’s My Story with Lupus.

If you have been living with systemic lupus erythematosus (SLE), commonly known as lupus, you may be eligible to participate in the Tulip SLE Study.

About the Tulip SLE Study

Learn about the clinical research study and the investigational drug.

The goal of the Tulip SLE Study is to find out whether anifrolumab, an investigational drug, may help reduce symptoms of lupus and limit the need for other medications. During the study period, participants will be allowed to take their currently prescribed lupus medications.

You may qualify if you:

  • Are between 18 to 70 years of age.
  • Have active lupus symptoms (moderate-to-severe).
  • Are currently receiving prescription medication for lupus.

Why participate?

  • The Tulip Program gives you the chance to be a part of research for lupus.
  • A physician with expertise in SLE will closely monitor you.
  • All participants will receive the study drug and study-related care at no charge.


About SLE

Living with lupus can be challenging, but you are not alone.

SLE is the form of the disease most commonly known as lupus. It can affect many parts of the body, including the kidneys, brain or central nervous system, blood and blood vessels, skin, lungs, heart, and joints. Symptoms of SLE can vary from person to person, and can be recurring.

The Tulip Program represents AstraZeneca’s commitment to developing a potential investigational drug for SLE. It is only through clinical research that new investigational drugs can be developed, and participating in a clinical trial may allow you to play an even more active role in lupus research. It also helps our researchers, physicians, and participants better understand lupus.

Frequently Asked Questions (FAQs)

FAQs about clinical research studies

FAQs about the Tulip SLE Study

For more information about the Tulip SLE Study, call 866-914-6997.

As a symbol of beauty, the tulip is known for its fragile yet colorful petals. Year after year, the flower blooms to display its vibrancy and resilience. In a similar way, the Tulip Program constantly strives for the people living with lupus, so they can open up to life again and showcase their own beautiful lives.

Back to Top

Welcome to the Tulip Program

The Tulip Program is a series of clinical research studies evaluating an investigational drug for systemic lupus erythematosus (SLE) and lupus nephritis (LN).

Content on this site is intended for US RESIDENTS ONLY

By choosing to continue, you are confirming that you reside in the United States.

Continue to Site